Journal of Child Psychology and Psychiatry, ISSN 0021-9630, 03/2014, Volume 55, Issue 3, pp. 247 - 255
Background Cogmed Working Memory Training (CWMT) has received considerable attention as a promising intervention for the treatment of...
ADHD | treatment | working memory | cognitive training | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | BEHAVIOR | ADOLESCENTS | PSYCHOLOGY, DEVELOPMENTAL | GROWTH | PSYCHOLOGY | Training | Intervention | Outcomes of Treatment | Attention Deficit Hyperactivity Disorder | Replication (Evaluation) | Children | Short Term Memory | Attention Deficit Disorder with Hyperactivity - physiopathology | Cognitive Therapy - methods | Attention Deficit Disorder with Hyperactivity - therapy | Humans | Placebos | Female | Male | Treatment Outcome | Memory, Short-Term - physiology | Child | Attention deficit disorder | Clinical trials | Parents & parenting | Child psychology | Behavior disorders
ADHD | treatment | working memory | cognitive training | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | BEHAVIOR | ADOLESCENTS | PSYCHOLOGY, DEVELOPMENTAL | GROWTH | PSYCHOLOGY | Training | Intervention | Outcomes of Treatment | Attention Deficit Hyperactivity Disorder | Replication (Evaluation) | Children | Short Term Memory | Attention Deficit Disorder with Hyperactivity - physiopathology | Cognitive Therapy - methods | Attention Deficit Disorder with Hyperactivity - therapy | Humans | Placebos | Female | Male | Treatment Outcome | Memory, Short-Term - physiology | Child | Attention deficit disorder | Clinical trials | Parents & parenting | Child psychology | Behavior disorders
Journal Article
Archives of Clinical Neuropsychology, ISSN 0887-6177, 09/2013, Volume 28, Issue 6, pp. 518 - 626
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2010, Volume 16, Issue 22, pp. 2416 - 2423
Chronic pediatric health conditions pose a significant challenge for youth, their families and professionals who treat these conditions. Long-term adherence to...
Adherence | ADHD | Compliance | Stimulant medication | Medication | Review | Pediatric | LIVER-TRANSPLANT RECIPIENTS | adherence | DEFICIT HYPERACTIVITY DISORDER | COMORBIDITY SURVEY REPLICATION | FOLLOW-UP | pediatric | CHILDREN | PHARMACOLOGICAL-TREATMENT | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | IMMEDIATE-RELEASE METHYLPHENIDATE | compliance | review | stimulant medication | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | Models, Theoretical | Humans | Social Support | Adolescent Behavior - drug effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Socioeconomic Factors | Patient Compliance - statistics & numerical data | Adolescent | Child Behavior - drug effects | Patient Compliance - psychology | Child | Chronic Disease | Patient Education as Topic
Adherence | ADHD | Compliance | Stimulant medication | Medication | Review | Pediatric | LIVER-TRANSPLANT RECIPIENTS | adherence | DEFICIT HYPERACTIVITY DISORDER | COMORBIDITY SURVEY REPLICATION | FOLLOW-UP | pediatric | CHILDREN | PHARMACOLOGICAL-TREATMENT | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | IMMEDIATE-RELEASE METHYLPHENIDATE | compliance | review | stimulant medication | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | Models, Theoretical | Humans | Social Support | Adolescent Behavior - drug effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Socioeconomic Factors | Patient Compliance - statistics & numerical data | Adolescent | Child Behavior - drug effects | Patient Compliance - psychology | Child | Chronic Disease | Patient Education as Topic
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2009, Volume 66, Issue 5, pp. 516 - 521
Objective Abnormalities in the morphology and function of two gray matter structures central to emotional processing, the perigenual anterior cingulate cortex...
Psychiatry | fMRI | bipolar disorder | magnetic resonance imaging | functional connectivity | Amygdala | diffusion tensor imaging | anterior cingulate cortex | ABNORMALITIES | PSYCHIATRY | EMOTION | SCHIZOPHRENIA | MANIA | NEUROSCIENCES | PREFRONTAL CORTEX | MONKEY | MOOD DISORDERS | ADOLESCENTS | DIFFUSION-TENSOR | FACIAL EXPRESSIONS | Amygdala - physiopathology | Humans | Bipolar Disorder - physiopathology | Facial Expression | Male | Neural Pathways - pathology | Amygdala - pathology | Magnetic Resonance Imaging | Temporal Lobe - physiopathology | Gyrus Cinguli - pathology | Bipolar Disorder - pathology | Gyrus Cinguli - physiopathology | Adult | Female | Neural Pathways - physiopathology | Diffusion Magnetic Resonance Imaging - methods | Bipolar disorder | Neurosciences
Psychiatry | fMRI | bipolar disorder | magnetic resonance imaging | functional connectivity | Amygdala | diffusion tensor imaging | anterior cingulate cortex | ABNORMALITIES | PSYCHIATRY | EMOTION | SCHIZOPHRENIA | MANIA | NEUROSCIENCES | PREFRONTAL CORTEX | MONKEY | MOOD DISORDERS | ADOLESCENTS | DIFFUSION-TENSOR | FACIAL EXPRESSIONS | Amygdala - physiopathology | Humans | Bipolar Disorder - physiopathology | Facial Expression | Male | Neural Pathways - pathology | Amygdala - pathology | Magnetic Resonance Imaging | Temporal Lobe - physiopathology | Gyrus Cinguli - pathology | Bipolar Disorder - pathology | Gyrus Cinguli - physiopathology | Adult | Female | Neural Pathways - physiopathology | Diffusion Magnetic Resonance Imaging - methods | Bipolar disorder | Neurosciences
Journal Article
Journal of Clinical Child & Adolescent Psychology, ISSN 1537-4416, 11/2013, Volume 42, Issue 6, pp. 769 - 783
The current review applied the evidence-based treatment criteria espoused by the Society for Clinical Child and Adolescent Psychology (Silverman & Hinshaw,...
MEDICATION | CONTROLLED-TRIAL | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | INTERVENTIONS | METAANALYSIS | DEFICIT HYPERACTIVITY DISORDER | ADOLESCENTS | PSYCHOLOGY, DEVELOPMENTAL | PSYCHOSOCIAL TREATMENTS | PARENT | PSYCHOLOGY, CLINICAL | CHILDREN | Attention Deficit Disorder with Hyperactivity - physiopathology | Attention Deficit Disorder with Hyperactivity - therapy | Humans | Adolescent | Cognitive Therapy | Treatment Outcome | Memory, Short-Term - physiology | Evidence-Based Medicine | Child | Randomized Controlled Trials as Topic | Practice | Care and treatment | Demographic aspects | Evidence-based medicine | Patient outcomes | Attention-deficit hyperactivity disorder | Attention deficit disorder | Mental health care | Memory | Children & youth | Adolescence | ADHD | Youth | Treatment | Cognitive Remediation | Cogmed Working Memory Training | Working Memory Training
MEDICATION | CONTROLLED-TRIAL | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | INTERVENTIONS | METAANALYSIS | DEFICIT HYPERACTIVITY DISORDER | ADOLESCENTS | PSYCHOLOGY, DEVELOPMENTAL | PSYCHOSOCIAL TREATMENTS | PARENT | PSYCHOLOGY, CLINICAL | CHILDREN | Attention Deficit Disorder with Hyperactivity - physiopathology | Attention Deficit Disorder with Hyperactivity - therapy | Humans | Adolescent | Cognitive Therapy | Treatment Outcome | Memory, Short-Term - physiology | Evidence-Based Medicine | Child | Randomized Controlled Trials as Topic | Practice | Care and treatment | Demographic aspects | Evidence-based medicine | Patient outcomes | Attention-deficit hyperactivity disorder | Attention deficit disorder | Mental health care | Memory | Children & youth | Adolescence | ADHD | Youth | Treatment | Cognitive Remediation | Cogmed Working Memory Training | Working Memory Training
Journal Article
Archives of Clinical Neuropsychology, ISSN 0887-6177, 01/2013, Volume 28, Issue 6, pp. 15 - 15
Objective: We present two detailed cases referred for neuropsychological evaluations following extensive cerebellar vascular injury due to arteriovenous...
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2001, Volume 41, Issue 12, pp. 1351 - 1358
A 21‐day, open‐label, multisite, dose escalation study comprising three demographic groups (children, adolescents, and adults) was performed to determine the...
DIAZEPAM | EFFICACY | OUTPATIENTS | SAFETY | PHARMACOLOGY & PHARMACY | SYMPTOMS | PHARMACOTHERAPY | Anti-Anxiety Agents - administration & dosage | Area Under Curve | Humans | Half-Life | Electrocardiography - drug effects | Male | Buspirone - pharmacokinetics | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Adolescent | Adult | Anti-Anxiety Agents - adverse effects | Female | Anxiety Disorders - metabolism | Anxiety Disorders - drug therapy | Buspirone - adverse effects | Child
DIAZEPAM | EFFICACY | OUTPATIENTS | SAFETY | PHARMACOLOGY & PHARMACY | SYMPTOMS | PHARMACOTHERAPY | Anti-Anxiety Agents - administration & dosage | Area Under Curve | Humans | Half-Life | Electrocardiography - drug effects | Male | Buspirone - pharmacokinetics | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Adolescent | Adult | Anti-Anxiety Agents - adverse effects | Female | Anxiety Disorders - metabolism | Anxiety Disorders - drug therapy | Buspirone - adverse effects | Child
Journal Article
Child Neuropsychology, ISSN 0929-7049, 05/2018, Volume 24, Issue 4, pp. 427 - 450
The present study examines the potential of sequencing a neurocognitive intervention with behavioral parent training (BPT) to improve executive functions...
ADHD | Behavioral parent training | Cognitive training | Combined treatment | Working memory training | COGNITIVE REMEDIATION | DEFICIT HYPERACTIVITY DISORDER | MIDDLE-CHILDHOOD | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | NONPHARMACOLOGICAL INTERVENTIONS | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | WORKING-MEMORY DEFICITS | ECONOMIC-IMPACT | OF-THE-LITERATURE | working memory training | combined treatment | behavioral parent training | cognitive training
ADHD | Behavioral parent training | Cognitive training | Combined treatment | Working memory training | COGNITIVE REMEDIATION | DEFICIT HYPERACTIVITY DISORDER | MIDDLE-CHILDHOOD | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | NONPHARMACOLOGICAL INTERVENTIONS | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | WORKING-MEMORY DEFICITS | ECONOMIC-IMPACT | OF-THE-LITERATURE | working memory training | combined treatment | behavioral parent training | cognitive training
Journal Article
Child and Adolescent Psychiatric Clinics of North America, ISSN 1056-4993, 07/2013, Volume 22, Issue 3, pp. 457 - 477
This article provides a select review of treatments for addressing reading disorder, mathematics disorder, disorder of written expression, auditory processing...
Intervention | Learning disorders | Treatment | Auditory processing disorders | Youth | Children | Working memory | Adolescents | READING DISABILITIES | LANGUAGE IMPAIRMENT | PSYCHIATRY | STRATEGY INSTRUCTION | MIDDLE SCHOOL STUDENTS | FAST FORWORD | DYSLEXIA | PROBLEM-SOLVING INSTRUCTION | WORKING-MEMORY | Auditory Perceptual Disorders - therapy | Learning Disorders - therapy | Humans | Mathematical Concepts | Writing | Treatment Outcome | Cognition Disorders - therapy | Memory, Short-Term | Child
Intervention | Learning disorders | Treatment | Auditory processing disorders | Youth | Children | Working memory | Adolescents | READING DISABILITIES | LANGUAGE IMPAIRMENT | PSYCHIATRY | STRATEGY INSTRUCTION | MIDDLE SCHOOL STUDENTS | FAST FORWORD | DYSLEXIA | PROBLEM-SOLVING INSTRUCTION | WORKING-MEMORY | Auditory Perceptual Disorders - therapy | Learning Disorders - therapy | Humans | Mathematical Concepts | Writing | Treatment Outcome | Cognition Disorders - therapy | Memory, Short-Term | Child
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 06/2000, Volume 20, Issue 6P2, pp. 49S - 58S
Study Objectives. To examine single‐ and multiple‐dose safety, tolerability and pharmacokinetics of gatifloxacin administered as daily 1‐hour intravenous...
SITE | PHARMACOLOGY & PHARMACY | CIPROFLOXACIN | VOLUNTEERS | TROVAFLOXACIN | Fluoroquinolones | Islets of Langerhans - drug effects | Glucose Tolerance Test | Anti-Infective Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Electrocardiography - drug effects | Male | Reference Values | Anti-Infective Agents - administration & dosage | Anti-Infective Agents - pharmacokinetics | Adult | Infusions, Intravenous
SITE | PHARMACOLOGY & PHARMACY | CIPROFLOXACIN | VOLUNTEERS | TROVAFLOXACIN | Fluoroquinolones | Islets of Langerhans - drug effects | Glucose Tolerance Test | Anti-Infective Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Electrocardiography - drug effects | Male | Reference Values | Anti-Infective Agents - administration & dosage | Anti-Infective Agents - pharmacokinetics | Adult | Infusions, Intravenous
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 07/1999, Volume 39, Issue 7, pp. 685 - 694
Avitriptan, a selective 5‐HT1‐like receptor agonist, is an effective compound for the treatment of migraine headaches with a prolonged duration of response. A...
PHARMACOLOGY & PHARMACY | SUMATRIPTAN | RECEPTOR AGONIST | MIGRAINE | 311C90 | Pharyngeal Diseases - chemically induced | Diastole | Double-Blind Method | Area Under Curve | Humans | Male | Systole | Serotonin Receptor Agonists - adverse effects | Pressure | Sulfonamides - pharmacokinetics | Dose-Response Relationship, Drug | Sensation - drug effects | Indoles - adverse effects | Serotonin Receptor Agonists - pharmacokinetics | Electrocardiography | Sulfonamides - adverse effects | Adult | Female | Indoles - pharmacokinetics | Anxiety - chemically induced | Blood Pressure - drug effects | Infusions, Intravenous | Tryptamines | Paresthesia - chemically induced
PHARMACOLOGY & PHARMACY | SUMATRIPTAN | RECEPTOR AGONIST | MIGRAINE | 311C90 | Pharyngeal Diseases - chemically induced | Diastole | Double-Blind Method | Area Under Curve | Humans | Male | Systole | Serotonin Receptor Agonists - adverse effects | Pressure | Sulfonamides - pharmacokinetics | Dose-Response Relationship, Drug | Sensation - drug effects | Indoles - adverse effects | Serotonin Receptor Agonists - pharmacokinetics | Electrocardiography | Sulfonamides - adverse effects | Adult | Female | Indoles - pharmacokinetics | Anxiety - chemically induced | Blood Pressure - drug effects | Infusions, Intravenous | Tryptamines | Paresthesia - chemically induced
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/1999, Volume 65, Issue 2, pp. 132 - 132
Clinical Pharmacology & Therapeutics (1999) 65, 132–132; doi:
Journal Article
13.
Full Text
Omapatrilat: Neurohormonal and Pharmacodynamic Profile When Administered with Furosemide
The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2001, Volume 41, Issue 12, pp. 1291 - 1300
Pharmacodynamic effects of combination therapy with omapatrilat and furosemide were evaluated. Two groups of 13 healthy subjects each received furosemide 20 mg...
NEUTRAL ENDOPEPTIDASE INHIBITION | VASOPEPTIDASE INHIBITOR | RENAL-FUNCTION | ATRIAL-NATRIURETIC-FACTOR | GLOMERULAR-FILTRATION RATE | ACE-INHIBITION | PHARMACOLOGY & PHARMACY | CARDIOMYOPATHIC HAMSTERS | CONGESTIVE-HEART-FAILURE | ANGIOTENSIN-CONVERTING ENZYME | BLOOD-PRESSURE | Area Under Curve | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Thiazepines - adverse effects | Insulin - blood | Pyridines - adverse effects | Drug Interactions | Furosemide - adverse effects | Adult | Female | Renal Circulation - drug effects | Double-Blind Method | Natriuresis - drug effects | Diuretics - pharmacology | Furosemide - pharmacokinetics | Thiazepines - pharmacology | Thiazepines - pharmacokinetics | Neurotransmitter Agents - blood | Diuresis - drug effects | Potassium - urine | Hemodynamics - drug effects | Pyridines - pharmacology | Furosemide - pharmacology | Diuretics - adverse effects
NEUTRAL ENDOPEPTIDASE INHIBITION | VASOPEPTIDASE INHIBITOR | RENAL-FUNCTION | ATRIAL-NATRIURETIC-FACTOR | GLOMERULAR-FILTRATION RATE | ACE-INHIBITION | PHARMACOLOGY & PHARMACY | CARDIOMYOPATHIC HAMSTERS | CONGESTIVE-HEART-FAILURE | ANGIOTENSIN-CONVERTING ENZYME | BLOOD-PRESSURE | Area Under Curve | Humans | Middle Aged | Pyridines - pharmacokinetics | Male | Thiazepines - adverse effects | Insulin - blood | Pyridines - adverse effects | Drug Interactions | Furosemide - adverse effects | Adult | Female | Renal Circulation - drug effects | Double-Blind Method | Natriuresis - drug effects | Diuretics - pharmacology | Furosemide - pharmacokinetics | Thiazepines - pharmacology | Thiazepines - pharmacokinetics | Neurotransmitter Agents - blood | Diuresis - drug effects | Potassium - urine | Hemodynamics - drug effects | Pyridines - pharmacology | Furosemide - pharmacology | Diuretics - adverse effects
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2001, Volume 41, Issue 12, pp. 1351 - 1358
A 21-day, open-label, multisite, dose escalation study comprising three demographic groups (children, adolescents, and adults) was performed to determine the...
Journal Article
The Annals of Pharmacotherapy, ISSN 1060-0280, 05/1999, Volume 33, Issue 5, pp. 525 - 530
OBJECTIVE: TO evaluate the pharmacokinetic interaction and bioequivalence of a combination formulation of the angiotensin-converting enzyme inhibitor...
Angiotensin-converting enzyme inhibitor | Fosinopril | Hydrochlorothiazide | angiotensin-converting enzyme inhibitor | hydrochlorothiazide | PHARMACOLOGY & PHARMACY | SERUM | HYPERTENSION | BLOOD-PRESSURE | fosinopril | Hydrochlorothiazide - adverse effects | Hydrochlorothiazide - pharmacokinetics | Sodium Chloride Symporter Inhibitors - pharmacokinetics | Humans | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Fosinopril - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Cross-Over Studies | Fosinopril - pharmacokinetics | Drug Interactions | Adolescent | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adult | Fosinopril - administration & dosage | Drug Combinations
Angiotensin-converting enzyme inhibitor | Fosinopril | Hydrochlorothiazide | angiotensin-converting enzyme inhibitor | hydrochlorothiazide | PHARMACOLOGY & PHARMACY | SERUM | HYPERTENSION | BLOOD-PRESSURE | fosinopril | Hydrochlorothiazide - adverse effects | Hydrochlorothiazide - pharmacokinetics | Sodium Chloride Symporter Inhibitors - pharmacokinetics | Humans | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Fosinopril - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Cross-Over Studies | Fosinopril - pharmacokinetics | Drug Interactions | Adolescent | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adult | Fosinopril - administration & dosage | Drug Combinations
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 02/1997, Volume 17, Issue 1, pp. 27 - 33
The effect of nefazodone on the pharmacokinetics of a single dose of phenytoin was evaluated in 18 healthy male subjects. The subjects received a single oral...
ANTIDEPRESSANT | DRUG-INTERACTIONS | PSYCHIATRY | MAJOR DEPRESSION | BENZODIAZEPINES | FLUOXETINE | CLINICAL NEUROLOGY | K VE PSYCHIATRY | DOUBLE-BLIND | IMIPRAMINE | PHARMACOLOGY & PHARMACY | K TU PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | K RT CLINICAL NEUROLOGY | Antidepressive Agents, Second-Generation - pharmacokinetics | Anticonvulsants - pharmacokinetics | Piperazines | Drug Administration Schedule | Administration, Oral | Humans | Anticonvulsants - administration & dosage | Male | Antidepressive Agents, Second-Generation - pharmacology | Phenytoin - administration & dosage | Dose-Response Relationship, Drug | Triazoles - pharmacology | Drug Interactions | Adolescent | Adult | Triazoles - pharmacokinetics | Metabolic Clearance Rate - drug effects | Drug Monitoring | Phenytoin - pharmacokinetics
ANTIDEPRESSANT | DRUG-INTERACTIONS | PSYCHIATRY | MAJOR DEPRESSION | BENZODIAZEPINES | FLUOXETINE | CLINICAL NEUROLOGY | K VE PSYCHIATRY | DOUBLE-BLIND | IMIPRAMINE | PHARMACOLOGY & PHARMACY | K TU PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | K RT CLINICAL NEUROLOGY | Antidepressive Agents, Second-Generation - pharmacokinetics | Anticonvulsants - pharmacokinetics | Piperazines | Drug Administration Schedule | Administration, Oral | Humans | Anticonvulsants - administration & dosage | Male | Antidepressive Agents, Second-Generation - pharmacology | Phenytoin - administration & dosage | Dose-Response Relationship, Drug | Triazoles - pharmacology | Drug Interactions | Adolescent | Adult | Triazoles - pharmacokinetics | Metabolic Clearance Rate - drug effects | Drug Monitoring | Phenytoin - pharmacokinetics
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 11/1995, Volume 35, Issue 11, pp. 1109 - 1118
Potential interactions between nefazodone (200 mg every 12 hours) and propranolol (40 mg every 12 hours) were assessed in 18 healthy male volunteers in an...
LONG-ACTING PROPRANOLOL | PHARMACOLOGY & PHARMACY | METABOLITES | 4-HYDROXYPROPRANOLOL | Antidepressive Agents, Second-Generation - pharmacokinetics | Triazoles - administration & dosage | Piperazines | Triazoles - blood | Humans | Adrenergic beta-Agonists - pharmacokinetics | Male | Antidepressive Agents, Second-Generation - pharmacology | Antidepressive Agents, Second-Generation - administration & dosage | Antidepressive Agents, Second-Generation - blood | Propranolol - pharmacokinetics | Cross-Over Studies | Triazoles - pharmacology | Heart Rate - drug effects | Drug Interactions | Propranolol - administration & dosage | Adolescent | Adrenergic beta-Agonists - administration & dosage | Adrenergic beta-Agonists - blood | Adult | Triazoles - pharmacokinetics | Drug Therapy, Combination | Propranolol - blood
LONG-ACTING PROPRANOLOL | PHARMACOLOGY & PHARMACY | METABOLITES | 4-HYDROXYPROPRANOLOL | Antidepressive Agents, Second-Generation - pharmacokinetics | Triazoles - administration & dosage | Piperazines | Triazoles - blood | Humans | Adrenergic beta-Agonists - pharmacokinetics | Male | Antidepressive Agents, Second-Generation - pharmacology | Antidepressive Agents, Second-Generation - administration & dosage | Antidepressive Agents, Second-Generation - blood | Propranolol - pharmacokinetics | Cross-Over Studies | Triazoles - pharmacology | Heart Rate - drug effects | Drug Interactions | Propranolol - administration & dosage | Adolescent | Adrenergic beta-Agonists - administration & dosage | Adrenergic beta-Agonists - blood | Adult | Triazoles - pharmacokinetics | Drug Therapy, Combination | Propranolol - blood
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 07/1999, Volume 39, Issue 7, pp. 685 - 694
Avitriptan, a selective 5-HT1-like receptor agonist, is an effective compound for the treatment of migraine headaches with a prolonged duration of response. A...
Journal Article
19.
Full Text
Pharmacokinetics of Fosinopril and Hydrochlorothiazide in Healthy Elderly and Young Men
Clinical Drug Investigation, ISSN 1173-2563, 03/1999, Volume 17, Issue 3, pp. 225 - 231
Objective: This study evaluated the effect of advanced age on the single-dose and steady-state pharmacokinetics of the angiotensin converting enzyme inhibitor...
Fosinopril, pharmacokinetics | Hydrochlorothiazide, pharmacokinetics | Clinical-pharmacokinetics | Antihypertensives, pharmacokinetics | Elderly | Age-differences | PHARMACOLOGY & PHARMACY | SERUM | HYPERTENSION | COMBINATION THERAPY | AGE
Fosinopril, pharmacokinetics | Hydrochlorothiazide, pharmacokinetics | Clinical-pharmacokinetics | Antihypertensives, pharmacokinetics | Elderly | Age-differences | PHARMACOLOGY & PHARMACY | SERUM | HYPERTENSION | COMBINATION THERAPY | AGE
Journal Article